Gene expression in humans with diabetes and prediabetes: what have we learned about diabetes pathophysiology?

被引:33
作者
Patti, ME
机构
[1] Joslin Diabet Ctr, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
insulin resistance/genetics; diabetes mellitus; type II/genetics; muscle; skeletal/metabolism; oxidative phosphorylation; gene expression profiling; transcription factors/physiology;
D O I
10.1097/01.mco.0000134359.23288.72
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review Type 2 diabetes mellitus is characterized by insulin resistance and pancreatic beta-cell dysfunction. In high-risk individuals, the earliest detectable abnormality is insulin resistance in skeletal muscle. Impaired insulin-mediated signaling, gene expression, and glycogen synthesis, and the accumulation of intramyocellular triglycerides have all been linked with insulin resistance, but no specific defect responsible for insulin resistance and diabetes mellitus has been identified in humans. However, recent analyses of gene expression patterns in muscle tissue from metabolically characterized humans have highlighted new genes and pathways potentially important in the pathogenesis of diabetes mellitus. This review will summarize these data and highlight the potential importance of oxidative metabolism in diabetes pathophysiology. Recent findings Genomic analysis of skeletal muscle samples from patients with diabetes mellitus has revealed the reduced expression of genes encoding key enzymes in oxidative metabolism and mitochondrial function. Moreover, the same pattern of gene expression is also observed in insulin resistant 'prediabetic' individuals with normal glucose tolerance. Many of the genes dysregulated in both diabetes and 'prediabetes' are regulated by the transcription factor nuclear respiratory factor-1 and the peroxisome proliferator-activated receptor gamma co-activator 1. These data suggest a potential role for both genetic and environmental factors to modify the risk of diabetes by modifying the expression or activity of these transcriptional regulators. Summary Nuclear respiratory factor and peroxisome proliferator activated receptor gamma co-activator-1-dependent oxidative metabolic pathways may play a central, and potentially primary, role in the pathogenesis of type 2 diabetes. Additional studies will be required to identify upstream genetic and environmental determinants of this expression phenotype.
引用
收藏
页码:383 / 390
页数:8
相关论文
共 59 条
  • [1] The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
    Altshuler, D
    Hirschhorn, JN
    Klannemark, M
    Lindgren, CM
    Vohl, MC
    Nemesh, J
    Lane, CR
    Schaffner, SF
    Bolk, S
    Brewer, C
    Tuomi, T
    Gaudet, D
    Hudson, TJ
    Daly, M
    Groop, L
    Lander, ES
    [J]. NATURE GENETICS, 2000, 26 (01) : 76 - 80
  • [2] [Anonymous], 2003, NAT DIAB FACT SHEET
  • [3] Evidence of a novel quantitative-trait locus for obesity on chromosome 4p in Mexican Americans
    Arya, R
    Duggirala, R
    Jenkinson, CP
    Almasy, L
    Blangero, J
    O'Connell, P
    Stern, MP
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 74 (02) : 272 - 282
  • [4] Skeletal muscle overexpression of nuclear respiratory factor 1 increases glucose transport capacity
    Baar, K
    Song, Z
    Semenkovich, CF
    Jones, TE
    Han, DH
    Nolte, LA
    Ojuka, EO
    Chen, M
    Holloszy, JO
    [J]. FASEB JOURNAL, 2003, 17 (12) : 1666 - 1673
  • [5] Free fatty acids in obesity and type 2 diabetes:: defining their role in the development of insulin resistance and β-cell dysfunction
    Boden, G
    Shulman, GI
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 : 14 - 23
  • [6] Role of brain insulin receptor in control of body weight and reproduction
    Brüning, JC
    Gautam, D
    Burks, DJ
    Gillette, J
    Schubert, M
    Orban, PC
    Klein, R
    Krone, W
    Müller-Wieland, D
    Kahn, CR
    [J]. SCIENCE, 2000, 289 (5487) : 2122 - 2125
  • [7] A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance
    Bruning, JC
    Michael, MD
    Winnay, JN
    Hayashi, T
    Horsch, D
    Accili, D
    Goodyear, LJ
    Kahn, CR
    [J]. MOLECULAR CELL, 1998, 2 (05) : 559 - 569
  • [8] Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women
    Buchanan, TA
    Xiang, AH
    Peters, RK
    Kjos, SL
    Marroquin, A
    Goico, J
    Ochoa, C
    Tan, S
    Berkowitz, K
    Hodis, HN
    Azen, SP
    [J]. DIABETES, 2002, 51 (09) : 2796 - 2803
  • [9] Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
    Bustin, SA
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2000, 25 (02) : 169 - 193
  • [10] Insulin resistance differentially affects the PI3-kinase- and MAP kinase-mediated signaling in human muscle
    Cusi, K
    Maezono, K
    Osman, A
    Pendergrass, M
    Patti, ME
    Pratipanawatr, T
    DeFronzo, RA
    Kahn, CR
    Mandarino, LJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (03) : 311 - 320